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 LETTER TO THE EDITOR 
 OPCAB Surgery is cost-effective 
for elderly patients 
 Dear Dr. Gjesdal 
 Thank you for forwarding the letter by Wagner 
and colleagues about our paper regarding cost-
effectiveness of off-pump and on-pump bypass in the 
June 2013 issue of the Scandinavian Cardiovascular 
Journal (1). 
 We would like to thank the letter writers for their 
interest in the study and to congratulate them on the 
similar study that they have published with data from 
the VA ROOBY trial (2). 
 We disagree with the main comment regarding 
the interpretation of the results. The argument that 
our conclusion about cost-effectiveness is wrong 
because the results are not statistically signifi cant is 
controversial and not universally accepted by health 
economists. Several arguments have been put forth 
against the use of formal hypothesis testing of cost 
and cost-effectiveness data. One argument is that the 
total costs are composed not only of measured costs 
but also estimated costs. As an example the cost of 
a stay in a ward at a hospital includes a component 
of rent and cleaning costs that can only be estimated. 
Thus, costs are not exact. Costs are per defi nition 
estimates. Secondly, most often, as in the cases of 
the VA ROOBY and DOORS studies, clinical trials 
are not powered with the cost-effectiveness study as 
the primary outcome measure for which reason the 
risk of a Type II error is likely to be refl ected in the 
economic evaluation. Thirdly, for the decision-maker 
who wants to use cost-effectiveness data, the differ-
ence between the two sample means remains the 
best estimate of effect difference rather than zero 
(whether this is statistically signifi cant or not). 
Fourth, in economic decision making, a p value of 
0.05 is not universally accepted as a threshold and 
a decision-maker may be willing to accept a higher 
risk of inappropriately rejecting a null hypothesis. A 
good overview of these discussions has been given 
by Drummond and coworkers (3). 
 As a consequence of these methodological and 
statistical diffi culties most health economists favor a 
Bayesian rather than a stochastic analysis paradigm. 
This type of analysis focuses on the probability of one 
treatment modality being more cost-effective than the 
other, taking into account the societal willingness to 
pay. In this context this is seen as a valid alternative 
to formal testing of a null hypothesis. We have pre-
sented these data in the paper in Figure 3. We base 
our conclusion, that off-pump surgery is more cost-
effective, on the very high ICER base-case point esti-
mate (6,829,999 D.kr./QALY) and on the 89% 
probability of off-pump being cost-effective at a 
threshold value similar to UK NICE guidelines. 
 In response to the two minor questions: 
 The letter writers have correctly spotted a 1. 
typing error regarding the costs given in 
Table IIb, as stated in the text of the  “ results ” 
section of the paper, they are mean values, not 
median values. 
 The relatively few conversions from on-pump 2. 
to off-pump surgery tended to be less costly 
than the mean of the originally planned 
operations. One reason was the lower costs of 
hardware like stabilizers and intracoronary 
shunts compared to tubes, oxygenators, and 
fi lters. This may, of course, be different in 
other institutions. 
 Sincerely 
 Kim  Houlind 
 Department of Cardiothoracic Surgery, 
Aarhus University Hospital, Aarhus, Denmark 
 Lars  Ehlers 
 Department of Business and Management, 
Aalborg University, Aalborg, Denmark 
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